{"acquisitions":[],"changes":[{"companyHref":"/c/liberatebio-com","date":"2026-09-27","documentUrl":null,"domain":"liberatebio.com","fact":"latest round","name":"Liberate Bio","new":{"amountUsd":31000000,"date":"2024-06-01","lead":null,"type":"seed"},"old":{"amountUsd":31000000,"date":"2024-06-01","lead":"khosla","type":"seed"},"publisher":"vc-portfolio","reason":null,"retrievedAt":"2026-05-25","slug":"liberatebio-com","status":"attributed","url":"https://whoraisedwhat.com/c/liberatebio-com"},{"companyHref":"/c/liberatebio-com","date":"2026-09-27","documentUrl":"https://www.khoslaventures.com/portfolio","domain":"liberatebio.com","fact":"provenance:investor:khosla","name":"Liberate Bio","new":{"publisher":"Khosla Ventures","status":"sourced","url":"https://www.khoslaventures.com/portfolio"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Khosla Ventures","reason":null,"retrievedAt":"2026-09-27","slug":"liberatebio-com","status":"sourced","url":"https://whoraisedwhat.com/c/liberatebio-com"}],"country":"US","description":"Liberate Bio develops genetic medicines using its RAPTOR platform to deliver therapeutic payloads to disease-causing cells that have been hard to reach. It targets patients with blood cancers and autoimmune diseases involving immune cells in blood and marrow. Its delivery tech reaches cell populations once inaccessible to genetic medicines.","domain":"liberatebio.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":"unknown","githubStars":null,"industry":"unknown","industrySources":[],"investors":["khosla"],"lat":null,"lng":null,"location":"US","multiples":[],"name":"Liberate Bio","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":31000000,"connectionsAmong":[],"currency":"USD","date":"2024-06-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"liberatebio-com-2024-06-01-seed","source":{"fact":"round","publisher":"vc-portfolio","retrievedAt":"2026-05-25","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"liberatebio-com","sources":[{"fact":"round","publisher":"vc-portfolio","retrievedAt":"2026-05-25","status":"attributed","url":null},{"fact":"existence","publisher":"liberatebio.com","retrievedAt":"2026-05-25","status":"self-reported","url":"https://liberatebio.com"},{"fact":"description","publisher":"liberatebio.com","retrievedAt":"2026-05-25","status":"self-reported","url":"https://liberatebio.com"},{"fact":"investor:khosla","publisher":"Khosla Ventures","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.khoslaventures.com/portfolio"}],"stage":"seed","stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Khosla Ventures\", \"role\": \"portfolio\", \"slug\": \"khosla\", \"sources\": [{\"publisher\": \"Khosla Ventures\", \"retrievedAt\": \"2026-09-27\", \"status\": \"sourced\", \"url\": \"https://www.khoslaventures.com/portfolio\"}]}","kind":"investor","sources":[{"publisher":"Khosla Ventures","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.khoslaventures.com/portfolio"}],"text":"Liberate Bio was listed in Khosla Ventures's portfolio, recorded 2026-09-27."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Khosla Ventures","role":"portfolio","slug":"khosla","sources":[{"publisher":"Khosla Ventures","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.khoslaventures.com/portfolio"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["unknown"],"totalRaisedUsd":31000000,"traction":[],"updatedAt":"2026-05-25","valuations":[]}